Lithostat (acetohydroxamic acid, from Mission) has been made available again after an 18 month hiatus.

Lithostat, a urease inhibitor, is indicated as adjunctive therapy in patients with chronic urea-splitting urinary infection.
It is available in 250mg strength tablets.

For more information call (800) 292-7364 or visit www.missionpharmacal.com.